Skip to site content

2024 Catalog: General Courses

To view other courses in this category, use the “Previous” and “Next” buttons. To select this course and request approval, please login. Need more help reading this page?



DE0978: IHS Pain & Opioid Disorder Webinar Series 5: Advancing Opioid Stewardship – Leveraging Local Strategies to Save Lives [2:00 EST]

 
Date: 8/05/2024 - 8/05/2024
Course Status: Available
Facility: Online
Location: Online
Level: Review
Audience: Dentists, Hygienists, Assistants, DHA
Quota: 5 - 1000 students
Tuition: $0.00
Hours: 1.00 (Total CDE); 1.00 (DANB Non-Clinical); 1.00 (AGD - 157)
Joint Sponsorship: Yes — IHS Clinical Support Center
Lecture icon Question and Answer icon
Summary:

This session will review Agency policy requirements specified in Special General Memorandum 24-04 Opioid Stewardship Management Plans and increase site awareness of October 1, 2024, implementation timeline. The session will also share an overview of available resources and tools to support sites in identifying relevant action plans and making progress toward safe opioid prescribing.

To Register: https://ihs-gov.zoomgov.com/webinar/register/WN_urdZte9LT6eyLjA2naoe_A

August 5, 2024 ? 2:00 pm EST, 1:00 pm CST, 12:00 pm MST, 11:00 am PST, 10:00 am AKST

Learning Objectives:

Upon completion of this course, participants will be able to:
1.   Develop local quality improvement initiatives to align with IHS Opioid Stewardship Management Plan policy requirements.
2.   Examine available metrics and understand processes to extract key performance indicators from the Opioid Surveillance Dashboard.
3.   Identify and utilize available evidence-based resources to support patient safety and quality of care initiatives.

Speaker / Presenter:

Cynthia Gunderson — For follow-up questions, please contact the speaker at cynthia.gunderson@ihs.gov.

Geniel Harrison — For follow-up questions, please contact the speaker at Geniel.Harrison@ihs.gov.

The speakers have no conflicts of interest to report. Dr. Geniel Harrison is the Chief Medical Officer at the Portland Area Indian Health Service. She provides clinical oversight and direction to the medical services and public health initiatives of the Portland Area Indian Health Service throughout Oregon, Washington, and Idaho. She also administers many aspects of the Area’s overall AI/AN health care programs. Prior to this position, she served as a Clinical Director at various health care facilities [Tribal and federal] since 2013. Dr. Harrison is a diplomat of the American Board of Family Medicine who has worked with the Indian Health Service for 13 years. She is an enrolled member of the Confederated Tribes of the Goshute Reservation located on the border of Utah and Nevada. CAPT Cynthia [Cindy] Gunderson is a United States Public Health Service Pharmacist with the Indian Health Service [IHS]. She is a 2004 graduate of the University of Nebraska Medical Center College Of Pharmacy. CAPT Gunderson serves as the Chair of the IHS National Committee on Heroin, Opioids, and Pain Efforts [HOPE] and Director of Revenue Enhancement for the Bemidji Area. In these dual roles, CAPT Gunderson leads diverse, interdisciplinary teams to identify opportunities for improvement, to engage key stakeholders, and to achieve success. CAPT Gunderson provides direction and supports IHS efforts to promote appropriate and effective pain management, to reduce overdose deaths, and to improve access to culturally appropriate treatment. She has a demonstrated passion for working with tribal communities to augment local responses to the opioid crisis and has led local initiatives to expand access to naloxone for opioid overdose reversal, improve maternal-child-health outcomes, and support innovative solutions to complex challenges.

Disclosure Policy:

It is the policy of the Indian Health Service, Division of Oral Health, that faculty/planners disclose any financial or other relationships with commercial companies whose products may be discussed in the educational activity. The Indian Health Service, Division of Oral Health, also requires that faculty disclose any unlabeled or investigative use of pharmaceutical products and medical devices. Images that have been falsified or manipulated to misrepresent treatment outcomes are prohibited.

None of the faculty/planners for this activity has a conflict of interest, and there is no use of unlabeled or investigative pharmaceutical products or medical devices. No images have been falsified or manipulated to misrepresent treatment outcomes.The educational objectives, content, and selection of educational methods and instructors are conducted independent of any commercial entity.

Accreditation:
The IHS Division of Oral Health is an ADA CERP Recognized Provider

The IHS Division of Oral Health is an accredited sponsor of continuing education under the American Dental Association Continuing Education Recognition Program (CERP). ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the IHS at IHS CDE Coordinator or to the Commission for Continuing Education Provider Recognition at CCEPR.ada.org

Prerequisites:

None

Tuition Payment Information:

Please Make Checks Payable to: Indian Health Service.

Tuition Policy:

Tuition must be paid in full 8 weeks prior to the start date of any course. Request for refunds must be received in writing at least two weeks before the course begins. For each refund request, there will be an administrative charge of $100. No refunds will be made to registrants who fail to attend a course. If IHS CDE program cancels a course, then 100% of the tuition will be refunded.